{
    "title": "115_hr2077",
    "content": "SECTION 1. SHORT TITLE.\n\n    This Act may be cited as the ``Restoring the Patient's Voice Act of \n2017''.\n\nSEC. 2. REQUIRED EXCEPTIONS PROCESS FOR MEDICATION STEP THERAPY \n              PROTOCOLS.\n\n    (a) In General.--The Employee Retirement Income Security Act of \n1974 is amended by inserting after section 715 of such Act (29 U.S.C. \n1185d) the following new section:\n\n``SEC. 716. REQUIRED EXCEPTIONS PROCESS FOR MEDICATION STEP THERAPY \n              PROTOCOLS.\n\n    ``(a) In General.--In the case of a group health plan (or health \ninsurance coverage offered in connection with such a plan) that \nprovides coverage of a prescription drug pursuant to a medication step \ntherapy protocol, the plan or coverage shall--\n            ``(1) implement a clear process for a participant or \n        beneficiary (or the prescribing health care provider) to \n        request an exception to such medication step therapy protocol; \n        and\n            ``(2) if such a request demonstrates through supporting \n        documentation that any of the circumstances listed in \n        subsection (b) exists, authorize coverage for the prescription \n        drug without regard to such medication step therapy protocol.\n    ``(b) Expedited Approval.--The circumstances warranting an \nexception to a medication step therapy protocol, pursuant to a request \nunder subsection (a), are any of the following:\n            ``(1) The treatment otherwise required under the protocol, \n        or a drug or drugs in the same pharmacological class, are \n        contraindicated or have been ineffective in the treatment of \n        the disease or condition of the participant or beneficiary.\n            ``(2) The treatment otherwise required under the protocol \n        is reasonably expected to be ineffective based upon--\n                    ``(A) the known physical or mental characteristics \n                of the participant or beneficiary, including medical \n                history; and\n                    ``(B) the known characteristics of such treatment.\n            ``(3) The treatment otherwise required under the protocol \n        will cause or is likely to cause an adverse reaction or other \n        physical harm to the participant or beneficiary.\n            ``(4) The treatment otherwise required under the protocol \n        is not in the best interest of the participant or beneficiary, \n        based on medical necessity, because the participant or \n        beneficiary's use of such treatment is expected to decrease the \n        participant or beneficiary's ability--\n                    ``(A) to achieve or maintain reasonable and safe \n                functional ability in performing daily activities or \n                occupational responsibilities; or\n                    ``(B) to adhere to the treatment plan as defined by \n                the prescribing health care provider.\n            ``(5) The participant or beneficiary is stable for his or \n        her disease or condition on the prescription drugs selected by \n        the prescribing health care provider.\n    ``(c) Clear Process.--The process required by subsection (a)(1) \nshall make information regarding such process readily available on the \nwebsite of the group health plan, including--\n            ``(1) the requirements for requesting an exception to a \n        medication step therapy protocol pursuant to this section; and\n            ``(2) any necessary forms and contact information.\n    ``(d) Timing for Granting Exception.--The process required by \nsubsection (a)(1) shall provide for the disposition of requests \nreceived under such paragraph in accordance with the following:\n            ``(1) Such a request shall be granted as quickly as the \n        disease or condition of the participant or beneficiary \n        requires, but no later than 3 days after the day of receipt of \n        the request.\n            ``(2) For circumstances in which the applicable medication \n        step therapy protocol may seriously jeopardize the life, \n        health, or ability to regain maximum function of the \n        participant or beneficiary, such a request shall be granted--\n                    ``(A) on an expedited basis; and\n                    ``(B) no later than 24 hours after receipt of such \n                request.\n    ``(e) Medication Step Therapy Protocol.--In this section, the term \n`step therapy protocol' means a protocol or program that establishes a \nspecific sequence in which prescription drugs that--\n            ``(1) are for a specified disease or condition, and\n            ``(2) are medically necessary for a particular patient,\nare covered under a pharmacy or medical benefit by a group health plan \nor a health insurance issuer offering group or individual health \ninsurance coverage.''.\n    (b) Technical Correction; Clerical Change.--The table of contents \nin section 1 of the Employee Retirement Income Security Act of 1974 (29 \nU.S.C. 1001 et seq.) is amended by inserting after the item relating to \nsection 714 the following new items:\n\nSec. 715. Additional market reforms.\nSec. 716. Required exceptions process for medication step therapy \n                            protocols.\n    (c) Effective Date.--The amendment made by subsection (a) applies \nto plan years beginning no sooner than 6 months after the date of \nenactment of this Act."
}